In order to offer you the very best service available, this website uses cookies. By continuing to browse, you accept their use. To find out more click here..

BioMers Series B financing

Project No: #19001
Capital needed
USD 5,000,000
Share with a friend Report as Fraud Print Add to favorites
Minimum investment per investor: USD1000000
Country: Singapore
Reason for needing Capital: Sales & Marketing
Stage: Finished product
Ideal Investor Role: Working partner
Highlights: Product and business model are validated.
With FDA 510k, CE, HSA, Malaysia FDA approvals.
Strong project team mixed with marketing and technology specialists.
Strong IP and sustainable technology roadmap.
What you offer to investors?: For US$5m, we give 18% company shares to the investor.

BioMers is a Singapore based medical device company specialized in material application in orthodontic treatment, its flagship product, SimpliClear, is a transparent, custom, fixed orthodontic treatment appliance. The manufacturing process involves intraoral scan, AI product design, 3D printing and manufacturing automation. SimpliClear promotes aesthetic, patient comfort and shorter chair-side time. With SimpliClear, caregiver is able to treat patient more accurate, faster and simple. It has received regulators' approval, such as US FDA, EU CE, Singapore HSA, Malaysia FDA and more. It won many international startup competitions.  

BioMers is seeking for USD5mil to expand business worldwide. We look forward to hear from you!
Thank you!

Mike Yang

Similar Projects